News

BioStat® Research
& Development Centre

2024 2023 2022 older
Biostat 6th consecutive year as research and development center
18
October
2024
Biostat 6th consecutive year as research and development center
The Minister of Development and Technology has decided to maintain Biostat's status as a research and development...
Study on generalized myasthenia gravis for AstraZeneca
09
October
2024
Study on generalized myasthenia gravis for AstraZeneca
The Biostat Research and Development Center will carry out another project in collaboration with AstraZeneca. T...
Study of new solutions in surgery for Corza Medical
26
August
2024
Study of new solutions in surgery for Corza Medical
The Biostat Research and Development Center has signed an agreement with Corza Medical to conduct a PASS study in the...
Aneta Piechaczek, Phd from Biostat co-authors a wcientific article
21
August
2024
Aneta Piechaczek, Phd from Biostat co-authors a wcientific article
Marek Kluszczyński, MD, who specializes in the rehabilitation of children and adolescents, has published a scientific...
Biostat will conduct a medical experiment for Stallergenes Greer
17
July
2024
Biostat will conduct a medical experiment for Stallergenes Greer
Biostat Research and Development Center has signed an agreement with a pharmaceutical company Stallergenes Greer to c...
Cooperation of Biostat and Medinice. Doctors used the CoolCryo system during surgery
09
July
2024
Cooperation of Biostat and Medinice. Doctors used the CoolCryo system during surgery
The innovative CoolCryo® system for cardiac cryoablation, for which Biostat is conducting a clinical trial,...
Biostat will conduct a non-interventional study for Adamed Pharma
27
June
2024
Biostat will conduct a non-interventional study for Adamed Pharma
A non-interventional study among cardiology patients - this is a new field of cooperation between the Biostat R...
Biostat listed in the Forbes ranking
21
May
2024
Biostat listed in the Forbes ranking
For another year in a row, Biostat Research and Development Center has been recognized in the ranking of the most dyn...
Biostat and MSD Polska collaborate on lung cancer study
16
May
2024
Biostat and MSD Polska collaborate on lung cancer study
The Biostat Research and Development Centre starts cooperation with the MSD Polska pharmaceutical company. ...
Post-stroke aphasia. Biostat in a clinical trial in the US
15
February
2024
Post-stroke aphasia. Biostat in a clinical trial in the US
Biostat's Research and Development Center has prepared a randomization system for a clinical trial being conducte...
It's been a good year! Summary of 2023 at Biostat
12
February
2024
It's been a good year! Summary of 2023 at Biostat
It's been a good year! Summary of 2023 at Biostat We summarize 2023 at Biostat Group. We are p...
10
November
2017
10
November
2017

eCRF.biz™ – new system version that leads the medical-pharmaceutical market

eCRF.biz™ – new system version that leads the medical-pharmaceutical market

eCRF.biz™ – new system version that leads the medical-pharmaceutical market

Handling clinical research and research programs has never been that easy. eCRF.bizTM System which has been for several years a reliable tool for comprehensive realisation of research projects is available now in 2.0 version what offers even more benefits for its Users. The latest update concerns:

- personalisation of graphic elements on the research webpage, research questionnaire as well as the research domain name;

- Implementation of the SaaS model to the management panel which promotes research self-handling;

- a new conditions editor, which facilitates their grouping and implementation.

Additionally, thanks to many years of experience in working with research questionnaires we have developed even more profitable tool for creating and setting up the cafeteria questions. Among numerous practicalities one can find, inter alia: collective actions on selected items, group conditions, making questions out of scripts, making questions out of Word files and full cafeteria questions responsiveness.

The implementation of internal system used for communication between subjects, researchers and administrators allows to have a smooth flow of information between the Users, what guarantees the best quality of the overall process. We have also raised the standards in terms of data security, which are encrypted with Blowfish algorithm and their replication takes place simultaneously on different devices.

In terms of constantly changing digital aspect and legal requirements we optimise our system which tends to become the leader in its category. Righteous research and records running with 100% data safety equals with the highest quality as well as project managers’ cool head which is guaranteed by the eCRF.bizTM. Start from now on and move your paper work into virtual reality along with eCRF.bizTM.

 

>Learn more about Biostat's clinical research services 

Copyright© 2023 Biostat